BioArctic AB (publ) (STO:BIOA.B)
341.80
+9.20 (2.77%)
At close: Apr 14, 2026
BioArctic AB Employees
BioArctic AB had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year.
Employees
131
Change
24
Growth
22.43%
Revenue / Employee
15.26M SEK
Profits / Employee
7.80M SEK
Market Cap
30.32B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Sep 30, 2025 | 122 | 18 | 17.31% |
| Jun 30, 2025 | 119 | 23 | 23.96% |
| Mar 31, 2025 | 116 | 26 | 28.89% |
| Dec 31, 2024 | 107 | 19 | 21.59% |
| Sep 30, 2024 | 104 | 21 | 25.30% |
| Jun 30, 2024 | 96 | 21 | 28.00% |
| Mar 31, 2024 | 90 | 21 | 30.43% |
| Dec 31, 2023 | 88 | 27 | 44.26% |
| Sep 30, 2023 | 83 | 27 | 48.21% |
| Jun 30, 2023 | 75 | 19 | 33.93% |
| Mar 31, 2023 | 69 | 14 | 25.45% |
| Dec 31, 2022 | 61 | 12 | 24.49% |
| Sep 30, 2022 | 56 | 7 | 14.29% |
| Jun 30, 2022 | 56 | 9 | 19.15% |
| Mar 31, 2022 | 55 | 8 | 17.02% |
| Dec 31, 2021 | 49 | 4 | 8.89% |
| Sep 30, 2021 | 49 | 4 | 8.89% |
| Jun 30, 2021 | 47 | 2 | 4.44% |
| Mar 31, 2021 | 47 | 4 | 9.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Camurus AB | 285 |
| Hansa Biopharma AB | 133 |
| BioInvent International AB | 124 |
| Egetis Therapeutics AB | 40 |
| Vicore Pharma Holding AB | 36 |
| Genovis AB (publ.) | 36 |
| Saniona AB | 34 |
| Xspray Pharma AB | 26 |
BioArctic AB News
- 18 days ago - The Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic AB - PRNewsWire
- 22 days ago - New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress - PRNewsWire
- 6 weeks ago - Number of shares and votes in BioArctic AB (publ) as of February 27, 2026 - PRNewsWire
- 7 weeks ago - BioArctic Interim Report for the period October - December 2025 - PRNewsWire
- 2 months ago - Invitation to presentation of BioArctic's fourth quarter report for October - December 2025 on February 18 at 9.30 a.m. CET - PRNewsWire
- 2 months ago - BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China - PRNewsWire
- 2 months ago - Sales of Leqembi® totaled 20.7 billion yen in the fourth quarter 2025 - PRNewsWire
- 4 months ago - Leqembi included in China's commercial insurance innovative drug list - PRNewsWire